Two Sigma Advisers’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.1K | Sell |
26,828
-800
| -3% | -$1.91K | ﹤0.01% | 2241 |
|
|
2025
Q1 | $119K | Buy |
27,628
+13,400
| +94% | +$57.6K | ﹤0.01% | 2221 |
|
|
2024
Q4 | $122K | Sell |
14,228
-8,402
| -37% | -$72.3K | ﹤0.01% | 2195 |
|
|
2024
Q3 | $385K | Buy |
22,630
+15,140
| +202% | +$257K | ﹤0.01% | 1817 |
|
|
2024
Q2 | $113K | Buy |
7,490
+5,870
| +362% | +$88.6K | ﹤0.01% | 2308 |
|
|
2024
Q1 | $26.9K | Buy |
+1,620
| New | +$26.9K | ﹤0.01% | 2387 |
|